TMDX (TMDX)

$3.8B
Market Cap
22.5
P/E Ratio
2.08
Beta
Dividend Yield
Piotroski 7/9Altman Z 5.0 SafeBeneish M -0.76 Flag (> −2.22)ROIC−WACC -6.1%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 5.0 (above 3.0 safe zone threshold). Beneish M-Score of -0.76 exceeds the -2.22 academic threshold — earnings quality may warrant further review.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics reveal a distinct tension between high-quality earnings generation and capital allocation efficiency. While the company demonstrates robust profitability drivers with net margins at 31.4% and gross margins near 60%, suggesting strong pricing power or cost control, this operational leverage is being eroded by a negative ROIC-WACC spread of -6.1%. This indicates that current returns on invested capital fall short of the required hurdle rate, implying potential value destruction despite impressive revenue growth of 37.1% YoY. Qualitative risk metrics present a mixed picture; a Piotroski F-Score of 7/9 signals strong financial health and improving fundamentals, whereas an Altman Z-Score of 5.0 places the firm in safe territory regarding bankruptcy risk, yet the negative spread suggests management may be deploying capital into lower-yielding opportunities or facing significant reinvestment burdens that dilute shareholder value creation.

Valuation metrics reflect a market premium for growth that appears disconnected from current cash flow generation capabilities relative to cost of equity. Trading at 22.5x earnings is notably elevated compared to typical mature sectors, as the high P/E multiple implicitly assumes sustained acceleration in profitability or margin expansion that must outpace the WACC to justify the price. However, a DCF-based fair value estimate of $33 suggests the current market pricing may be aggressive if it fails to account for the drag imposed by the negative ROIC-WACC spread. The disparity between the high multiple and the cash flow reality implies the stock is priced on future growth expectations rather than present economic returns; any deviation from the projected 37% revenue trajectory or a failure to improve capital efficiency could trigger a significant re-rating downward, as the current valuation does not appear supported by existing operational performance.

Risk assessment highlights a divergence between solvency and value creation potential. Although the Beneish M-Score of -0.76 indicates low probability of earnings manipulation and the Altman Z-Score confirms stability against insolvency, the persistent negative spread acts as a structural headwind that limits total shareholder return regardless of top-line momentum. The data suggests an asymmetric risk profile where downside protection is supported by strong balance sheet metrics, yet upside potential remains constrained until capital allocation strategies shift to generate returns exceeding the 15.9% cost of equity. Investors must weigh whether the current valuation premium adequately compensates for the gap between revenue velocity and actual economic value creation.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →13.9%15.9%17.9%
2%$37$32$28
3%$40$33$29
4%$42$35$30

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=15.9%, terminal growth 3%. Fair value $33 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
5.0
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-0.76
Beneish M-Score
Above threshold — earnings quality may warrant further review per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

59.9%
Gross Margin
31.4%
Net Margin
9.8%
ROIC
15.9%
WACC
ROIC − WACC Spread: -6.1%— Negative spread.
+37.1%
Revenue Growth (YoY)
+436.6%
Earnings Growth (YoY)
133.6M
Free Cash Flow

Balance Sheet Health

1.26x
Debt / Equity
7.14x
Current Ratio
8.8x
Interest Coverage
0.1x
Net Debt / EBITDA
3.55%
FCF Yield
148.5M
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.24
Act: $0.70
+190.1%
Q3
✓ Beat
Est: $0.43
Act: $0.92
+114.8%
Q2
✓ Beat
Est: $0.36
Act: $0.66
+83.3%
Q1
✓ Beat
Est: $0.37
Act: $0.53
+41.0%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

29.7
Forward P/E
PEG Ratio
7.92
Price/Book
892716
Avg Volume
$156.00
52W High
$72.78
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$96M
Tracked Passive Exposure
7
ETFs Holding TMDX
0.09%
Avg Weight in ETFs
$103B
Total ETF AUM

When investors buy or sell ETFs like XHE or SLYG, the fund manager is mechanically forced to buy or sell TMDX shares regardless of TMDX's individual fundamentals. We estimate $96M of passive capital is structurally linked to TMDX through 7 tracked ETFs. Passive flows have a limited but growing influence on TMDX's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 7 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in TMDX to visualize passive redemption contagion across ETFs and collateral stocks.

TMDX Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
TMDXEpicenterVBKETFVHTETFVTWOETFGKOSUnknownSTAAUnknownBELow RiskNVCRUnknownTFXMed Risk
TMDX Price Drop (%)0

If TMDX (TMDX) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies GLAUKOS CORP (GKOS) as the most exposed collateral stock, sharing 3 ETFs with TMDX. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 7 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

TMDX Ownership Dynamics

Ticker
TMDX

Float lock-up computed from 8 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

TMDX Capital Efficiency

How efficiently does TMDX convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$134M
EBITDA
$148M
FCF Conversion
90%
Reinvestment Rate
10%
90% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
9.8%
ROIC − WACC Spread
-6.1%

TMDX converts 90% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-6.1%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-0718,854$72.92$1.4M
2026-05-062,216$94.93$210,364.88
2026-04-302,111$98.57$208,081.27
2026-04-221,008$108.91$109,781.28
2026-04-2094$115.87$10,891.78
2026-04-09194$109.36$21,215.84
2026-04-06975$100.70$98,182.5
2026-04-02339$100.40$34,035.6
2026-03-316,978$94.31$658,095.18
2026-03-2747$102.20$4,803.4
2026-03-23113$113.90$12,870.7
2026-03-19875$113.21$99,058.75
2026-03-18650$124.72$81,068
2026-03-17755$124.70$94,148.5
2026-03-16477$123.48$58,899.96
2026-03-0999,526$129.61$12.9M
2026-03-06320$140.07$44,822.4
2026-03-046,211$148.00$919,228
2026-03-032,052$147.00$301,644
2026-02-2425,126$134.65$3.4M
2026-02-2344,247$134.25$5.9M
2026-02-202,302$132.88$305,889.76
2026-02-1722,297$129.84$2.9M
2026-02-1326,340$128.52$3.4M
2026-02-1286$133.30$11,463.8
2026-02-1145,042$139.29$6.3M
2026-02-103,960$136.34$539,906.4
2026-02-095,193$135.06$701,366.58
2026-02-04149$135.72$20,222.28
2026-01-302,931$138.97$407,321.07

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare TMDX to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.